SetPoint Medical
SetPoint Medical raises $140M Series D at $650M valuation
Quick Facts
SetPoint Medical: Series D Funding Round
SetPoint Medical has successfully raised $140M in Series D funding, reaching a valuation of $650M.
Company Overview
Developer of therapies for rheumatoid arthritis using bioelectronics
Funding Details
The Series D round was led by Cowen Healthcare, with participation from Temasek.
Company Information
- Headquarters: Valencia, CA
- Founded: 2007
- Employees: 120+
- Category: HealthTech
Investment
SetPoint Medical plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Cowen Healthcare: Verified investor in Series D
- Temasek: Verified investor in Series D
Key Investors
About the Author
Related Company Reports
Zingage raises $12.5M Seed at $60M valuation
Zingage raises $12.5M in Seed at $60M valuation. AI platform for home healthcare coordination and patient engagement...
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.
Duos raises $130M Growth Equity at $600M valuation
Duos raises $130M in Growth Equity at $600M valuation. Digital health platform for Medicare-focused patient care...